Home › Breast Cancer › New York
Breast Cancer clinical trials in New York
184 studies for Breast Cancer are looking for participants at sites in New York.
Cities in New York
- New York City144 studies
- Queens67 studies
- Greenburgh45 studies
- Staten Island43 studies
- New Rochelle41 studies
- The Bronx18 studies
- Buffalo17 studies
- Rochester15 studies
- Brooklyn10 studies
- Yonkers6 studies
- Albany5 studies
- Syracuse5 studies
- Queensbury5 studies
- Shirley4 studies
- Manhattan4 studies
A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes
- NYU Langone Hospital Long Island Clinical Research, Mineola
- NYU Langone?s Perlmutter Cancer Center - 160 E 34th St, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07748208Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
- The Blavatnik Family - Chelsea Medical Center at Mount Sinai, New York
- Icahn School of Medicine at Mount Sinai, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT05696626A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
- New York Oncology Hematology - Amsterdam Cancer Center, Amsterdam
- Chelsea Medical Center at Mount Sinai, New York
- Montefiore Medical Center, The Bronx
- and 1 more
RecruitingPhase 1
Ages 18 to 55 · Women · Updated Nov 12, 2026 · NCT07310420A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)
- New York Oncology Hematology (Patroon) - USOR, Albany
RecruitingPhase 3
Ages 18 and older · Women · Updated Nov 12, 2026 · NCT07541079S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Nyack Hospital, Nyack
- Dickstein Cancer Treatment Center, White Plains
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03418961Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
- Research Facility, Buffalo
- Research Facility, New York
- Research Facility, New York
RecruitingPhase 1/2
All ages · All sexes · Updated Nov 12, 2026 · NCT06590857A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
- Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- and 1 more
RecruitingPhase 3
Ages 18 to 75 · Women · Updated Nov 10, 2026 · NCT06144164A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
- Memorial Sloan Kettering Cancer Center Westchester, Harrison
- Beth Israel Comprehensive Cancer Center, New York
- Mount Sinai Medical Center, New York
- and 5 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT06827236ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07007559Short-Term Reduced Dietary Protein in ER+/HER2- Breast Cancer Patients During Neoadjuvant Chemotherapy
- Stony Brook Cancer Center, Stony Brook
Recruiting
Ages 18 to 75 · Women · Updated Nov 6, 2026 · NCT07897344Decision Support for Chemoprevention
- Columbia University Irving Medical Center, New York
Recruiting
Ages 40 to 79 · Women · Updated Nov 6, 2026 · NCT07899151Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Memorial Sloan-Kettering Cancer Center, New York
- New York Cancer & Blood Specialists, Shirley
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT06324357A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy, Long Island City
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Memorial Sloan Kettering Cancer Center 53rd street., New York
- and 1 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07318805Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
- New York Cancer and Blood Specialists, Babylon
- NYU Langone Health, New York
- University of Rochester (URMC), Rochester
- and 1 more
Recruiting
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07214532Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
- NYU Langone Health Perlmutter Cancer Center, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT05315700A Study of Different Skin Care Approaches to Prevent Skin Reactions in People With Breast Cancer Receiving Radiation Therapy After Mastectomy
- Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities ), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
- and 1 more
RecruitingPhase 2
Ages 18 and older · Women · Updated Nov 5, 2026 · NCT07918989Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Irving Medical Center, New York
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT06982521A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- NYOH Albany Cancer Center, Albany
- New York University (NYU) Brooklyn, Brooklyn
- Memorial Sloan Kettering Cancer Center, New York
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07174336A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
- The Blavatnik Family ? Chelsea Medical Center at Mount Sinai, New York
- Mount Sinai West, New York
- Icahn School of Medicine at Mount Sinai, New York
- and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06790693E-Mindfulness Approaches for Living After Breast Cancer
- Mount Sinai Queens, Astoria
- Glens Falls Hospital, Glens Falls
- Garnet Health Medical Center, Middletown
- and 9 more
RecruitingPhase 3
Ages 18 to 50 · All sexes · Updated Nov 4, 2026 · NCT06748222A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
- Memorial Sloan Kettering Cancer Center, New York
- Wilmot Cancer Institute, Rochester
- New York Cancer and Blood Specialists, Shirley
RecruitingPhase 2
Ages 18 and older · Women · Updated Nov 4, 2026 · NCT07287098Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- and 1 more
RecruitingObservational study
Ages 18 and older · Women · Updated Nov 4, 2026 · NCT05590949Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Queens Hospital Center, Jamaica
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Stony Brook University Medical Center, Stony Brook
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Nov 4, 2026 · NCT05334069Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Glens Falls Hospital, Glens Falls
- Queens Hospital Center, Jamaica
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- and 8 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06418204A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- NYU Langone Health - Long Island, Mineola
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06400472A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07213791A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- New York University (NYU) Langone Medical Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07114601Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Northwell Health Imbert Cancer Center, Bay Shore
- New York-Presbyterian/Brooklyn Methodist Hospital, Brooklyn
- NYU Langone Hospital - Brooklyn, Brooklyn
- and 23 more
RecruitingPhase 3
Ages 18 to 60 · Women · Updated Nov 4, 2026 · NCT05879926A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Cancer
- Memorial Sloan Kettering Suffolk- Commack (Consent Only), Commack
- Memorial Sloan Kettering Westchester (Consent Only), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- and 1 more
Recruiting
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07218250A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
- Northwell Health Cancer Institute, Lake Success
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06695845A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
- Queens Hospital Cancer Center, Jamaica
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07405801A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- Queens Hospital Cancer Center ( Site 0011), Jamaica
- Optum Medical Care, PC ( Site 0009), Westbury
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07060807Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
- Memorial Sloan Kettering Cancer Ctr, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07660055MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
- Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
- and 1 more
Recruiting
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06954337ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
- Paradigm New York Cancer and Blood Specialists, Bay Shore
- Paradigm New York Cancer and Blood Specialists, New York
- Paradigm New York Cancer and Blood Specialists, New York
- and 9 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT07173751Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
- New York-Presbyterian/Weill Cornell Medical Center, New York
RecruitingPhase 4
Ages 18 and older · Women · Updated Oct 29, 2026 · NCT06072807A Study of Skipping Radiation Therapy in People With Breast Cancer
- Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities ), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
- and 1 more
Recruiting
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT07895511A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- Roswell Park Comprehensive Cancer Center, Buffalo
- Mount Sinai Tisch Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT06774963A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
- Hematology Oncology Associates of Central New York, Camillus
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT07102381A Study of a Side Effects and Resource Navigation Program for People With Cancer
- Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- City College of New York (Data Collection AND Specimen Analysis), New York
- and 2 more
Recruiting
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07646847From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.